HBOT Conversations:
Dr. Jay Stevens
Optimizing Health & Longevity
Dr. James “Jay” Stevens is the Medical Director of Extivita-RTP. He earned a Bachelor of Arts in Zoology from UNC-Chapel Hill and a Doctor of Medicine from East Carolina University School of Medicine. He completed a Family Practice Residency at the Fairfax Family Practice Program at the Medical College of Virginia and the first Sports Medicine Fellowship at the University of North Carolina, Chapel Hill in 1991. He is Board Certified in both Family Practice and Anti-aging Medicine. He also holds a Certificate of Added Qualification in Sports Medicine. In 2003 he founded Carolina Family Practice & Sports Medicine with locations in Cary, Raleigh, and Holly Springs, NC. He has served as the Team Physician for the National Hockey League’s 2006 Stanley Cup Champion Carolina Hurricanes since their arrival in 1997. He also serves as Company Physician for the Carolina Ballet.
Watch the Podcast
Dr. Jay Stevens, Medical Director at Extivta, returns to HBOT News Network to discuss ways to optimize your health & longevity. In addition to being the Medical Director at Extivita, Dr. Stevens is also the Medical Director & Provider for the Cary, NC location of Essential Health. Essential Health has many locations across the country.
We are lucky to have Dr. Stevens here to share the insightful data and information he has come across over the course of his career.
Dr. Stevens starts by explaining that there is in fact a difference between someone’s health span and life span. Health span can be defined or looked at by how long can someone live before they succumb to disease? While, life span is more along the lines of quality of life, and wanting to live as long as possible. With life span, a person wants to keep the body as young, disease-free and as healthy as possible. This is where longevity fits in, because it ultimately is the desire to achieve the longest life span possible. But, he reminds us that functional medicine can never exist without conventional medicine. They both play a part in someone’s longevity and keeping diseases away.
Yet, how exactly does Hyperbaric Oxygen Therapy play a part in a person’s longevity goals? Dr. Stevens states that he sees HBOT as elegant and simplistic; because to create energy, we require a nutrient and oxygen. It’s as simple as that. But, our environments keep mucking that process up — toxins, poor diet, too much sugar, etc. We must look at Hyperbaric Oxygen Therapy as a mechanism to improve cellular energy production. He further explains that when we focus on optimizing everything about the cell lifestyle and then apply oxygen, we have a recipe to achieve the best outcome in energy production. But, why is energy production so important for longevity?! Because energy production in your immune system predicts how your immune system will function – more energy production and your immune system is boosted to preform better, thus optimizing the chances of keeping disease and illness away.
The topic of the immune system leads us into a discussion on immunosenescence and why it is so important. Dr. Stevens explains that ultimately, the longevity of our lives is predicted by our immune system. Thankfully Hyperbaric Oxygen Therapy is known to slow down the rate of decline in an aging immune system, and increase our body’s ability to regenerate stem cells.
Dr. Stevens again touches on the power of extended fasting, and why it plays such an important role in optimal health & longevity.
Dr. Stevens starts by explaining that there is in fact a difference between someone’s health span and life span. Health span can be defined or looked at by how long can someone live before they succumb to disease? While, life span is more along the lines of quality of life, and wanting to live as long as possible. With life span, a person wants to keep the body as young, disease-free and as healthy as possible. This is where longevity fits in, because it ultimately is the desire to achieve the longest life span possible. But, he reminds us that functional medicine can never exist without conventional medicine. They both play a part in someone’s longevity and keeping diseases away.
Yet, how exactly does Hyperbaric Oxygen Therapy play a part in a person’s longevity goals? Dr. Stevens states that he sees HBOT as elegant and simplistic; because to create energy, we require a nutrient and oxygen. It’s as simple as that. But, our environments keep mucking that process up — toxins, poor diet, too much sugar, etc. We must look at Hyperbaric Oxygen Therapy as a mechanism to improve cellular energy production. He further explains that when we focus on optimizing everything about the cell lifestyle and then apply oxygen, we have a recipe to achieve the best outcome in energy production. But, why is energy production so important for longevity?! Because energy production in your immune system predicts how your immune system will function – more energy production and your immune system is boosted to preform better, thus optimizing the chances of keeping disease and illness away.
The topic of the immune system leads us into a discussion on immunosenescence and why it is so important. Dr. Stevens explains that ultimately, the longevity of our lives is predicted by our immune system. Thankfully Hyperbaric Oxygen Therapy is known to slow down the rate of decline in an aging immune system, and increase our body’s ability to regenerate stem cells.
Dr. Stevens again touches on the power of extended fasting, and why it plays such an important role in optimal health & longevity.
Guest
Dr. Jay Stevens
Dr. James “Jay” Stevens earned a Bachelor of Arts in Zoology from UNC-Chapel Hill and a Doctor of Medicine from East Carolina University School of Medicine. He completed a Family Practice Residency at the Fairfax Family Practice Program at the Medical College of Virginia and the first Sports Medicine Fellowship at the University of North Carolina, Chapel Hill in 1991. He is Board Certified in both Family Practice and Anti-aging Medicine. He also has a Certificate of Added Qualification in Sports Medicine. In 2003 he founded Carolina Family Practice & Sports Medicine with locations in Cary, Raleigh, and Holly Springs, NC. He has served as the Team Physician for the National Hockey League’s 2006 Stanley Cup Champion Carolina Hurricanes since their arrival in 1997. He serves as Company Physician for the Carolina Ballet as well.
In 2009, his commitment to helping his patients create healthy lifestyles for long-term wellness, along with his desire to provide the highest quality health care services, motivated Dr. Stevens to establish Essential Health & Wellness (EHW). EHW offers its patients a comprehensive health care service tailored around their busy schedules with the goal of optimizing their performance and longevity.
In 2018, he continued this commitment to long-term wellness of his patients by becoming the Medical Director at Extivita RTP, a hyperbaric oxygen therapy facility with two, twelve seat treatment chambers in the Research Triangle Park, Durham, NC.
Dr. Stevens is also a Fellow in both the American Academy of Anti-Aging and Regenerative Medicine and the American Academy of Family Practice. He is a member of the American Medical Society of Sports Medicine and Hyperbaric Medicine International.
Dr. Stevens lives in Cary, NC with his wife, Dr. Patience Stevens. They have three sons Eric, James, and Timothy. He is passionate about surfing, triathlon and almost any form of exercise.
Subscribe Now, It’s Free!
Recent HBOT News
Healing under pressure: Inside a military hyperbaric chamber
At 16, she had a stroke. At 17, her town burned in the Camp Fire. Now, as her community rebuilds, she's healing thanks to hyperbaric therapy. SACRAMENTO, Calif — February 2, 2017, started off as an ordinary day for the Pipkin Family. Patrick and Stacey Pipkin just...
Clinical Trial – High-flow Oxygen for Vaso-occlusive Pain Crisis
Sickle cell disease (SCD) is characterized by recurrent vaso-occlusive pain crisis (VOC),
which may evolve to acute chest syndrome (ACS), the most common cause of death among adult
patients with SCD. Currently, there is no safe and effective treatment to abort VOC or
prevent secondary ACS. Management of VOC mostly involve a symptomatic approach including
hydration, analgesics, transfusion, and incentive spirometry, which was investigated in a
very limited number of patients (<30).
The polymerisation of HbS is one major feature in the pathogenesis of vaso-occlusion. Among
factors determining the rate and extent of HbS polymer formation, the hypoxic stimulus is one
of the most potent and readily alterable. Current guidelines recommend oxygen therapy in
patients with VOC in order to maintain a target oxygen saturation of 95%. Low-flow nasal
oxygen (LFNO) is routinely used to achieve this normoxia approach, particularly in patients
at risk of secondary ACS because they may experience acute desaturation. In contrast, various
case series suggest a potential beneficial role of intensified oxygen therapy targeting
hyperoxia for the management of VOC, particularly with the use of hyperbaric oxygen, but the
latter is difficult to implement in routine clinical practice.
A recent high-flow nasal oxygen (HFNO) technology allows the delivery of humidified gas at
high fraction of inspired oxygen (FiO2) through nasal cannula. The FiO2 can be adjusted up to
100% (allowing hyperoxia that may reverse sickling) and the flow can be increased up to 60
L/min (which generates positive airway pressure and dead space flushing, that may prevent
evolution of VOC towards ACS by alleviating atelectasis and opioid-induced hypercapnia). In
patients with acute respiratory failure, HFNO has been shown to improve patient's comfort,
oxygenation, and survival as compared to standard oxygen or non-invasive ventilation.
The aim of the present study is to test the efficacy and safety of HFNO for the management of
VOC and prevention of secondary ACS. The investigators will use a multi-arm multi-stage
(MAMS) design to achieve these goals. HFNO will be delivered through AIRVO 2 (Fisher and
Paykel Healthcare, New Zealand), a device that incorporates a turbine allowing its use in
hospital wards.
Clinical Trial – Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
Subjects with Acute Myeloblastic Leukemia (AML) and myelodysplastic syndrome (MDS) who are
considered eligible for allogeneic stem cell transplant by the transplant team at WCI (Wilmot
Cancer Institute)will be enrolled in the study. Patients will receive Melphalan on day -2 and
HBO (Hyperbaric Oxygen) therapy on day 0 of the transplant. After neutrophil recovery is
documented, the patients will be seen in clinic at least weekly through day +100.